
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services is supported by a durable mix of scale and margin, with 346 inpatient behavioral health centers, 29 acute care hospitals, and supportive outpatient facilities generating more than 55% of revenue from acute care while behavioral health contributes over 55% of pretax profits. Its leadership in higher-margin behavioral services, especially across Nevada, Texas, and California, gives it attractive profit concentration, though Medicaid reimbursement headwinds and UK exposure add some earnings variability. Even after a tough 3Q26 and slower de novo ramp, improving volumes, cost controls, and new capacity maturation create a credible path to stronger margin expansion and better execution.
Bears say
Universal Health Services is facing a weakening earnings mix as acute care pricing deteriorates, with same-facility revenue per adjusted admission down 1.7% and SS acute margin falling to 11.3%, while surgeries continue migrating to outpatient settings. Behavioral health remains the higher-margin engine, but SS margin still slipped to 17.9% amid DPP headwinds, Laurel Ridge losses, and slower-than-expected de novo ramps at Cedar Hill and the new FL facility. Even with revenue guidance of $18.5B-$18.8B and FY2026 Adj EBITDA-MI toward the low end of $2,610MM-$2,717MM, the 2027 outlook is burdened by a $175MM-$200MM Medicaid supplemental reduction, at least a $15MM exchange headwind, and possible Medicaid work requirement pressure.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Universal Health Services (UHS) Forecast
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares